NCT03914157View on ClinicalTrials.gov

Ultrasound Wave Therapy for Post-stenotic Microvascular Remodeling

NAWithdrawnINTERVENTIONAL
0
Timeline

Start Date

March 31, 2023

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2027

Conditions
Renal Artery Stenosis
Interventions
DEVICE

Low-energy extracorporeal ultrasound shockwave therapy (SWT)

SWT delivers 10% energy of the traditional SWT used for clinically indicated lithotripsy, evokes neovascularization, and improves regional blood flow and function in various ischemic tissues.

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

Mayo Clinic

OTHER

NCT03914157 - Ultrasound Wave Therapy for Post-stenotic Microvascular Remodeling | Biotech Hunter | Biotech Hunter